These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31947899)

  • 1. Evaluation of Passive Immunity Induced by Immunisation Using Two Inactivated gE-deleted Marker Vaccines against Infectious Bovine Rhinotracheitis (IBR) in Calves.
    Petrini S; Righi C; Iscaro C; Viola G; Gobbi P; Scoccia E; Rossi E; Pellegrini C; De Mia GM
    Vaccines (Basel); 2020 Jan; 8(1):. PubMed ID: 31947899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of suckler cow vaccination against glycoprotein E (gE)-negative bovine herpesvirus type 1 (BoHV-1) on passive immunity and physiological response to subsequent bovine respiratory disease vaccination of their progeny.
    Earley B; Tiernan K; Duffy C; Dunn A; Waters S; Morrison S; McGee M
    Res Vet Sci; 2018 Jun; 118():43-51. PubMed ID: 29421483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody Responses to Bovine Alphaherpesvirus 1 (BoHV-1) in Passively Immunized Calves.
    Petrini S; Iscaro C; Righi C
    Viruses; 2019 Jan; 11(1):. PubMed ID: 30609738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Safety and Efficacy of an Inactivated Marker Vaccine against
    Petrini S; Martucciello A; Grandoni F; De Matteis G; Cappelli G; Giammarioli M; Scoccia E; Grassi C; Righi C; Fusco G; Galiero G; Pela M; De Mia GM; De Carlo E
    Vaccines (Basel); 2021 Apr; 9(4):. PubMed ID: 33917160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Hematological Profiles and Monocyte Subpopulations in Water Buffalo Calves after Immunization with Two Different IBR Marker Vaccines and Subsequent Infection with
    Grandoni F; Hussen J; Signorelli F; Napolitano F; Scatà MC; De Donato I; Cappelli G; Galiero G; Grassi C; De Carlo E; Petrini S; De Matteis G; Martucciello A
    Vaccines (Basel); 2023 Aug; 11(9):. PubMed ID: 37766082
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of an inactivated, recombinant bovine herpesvirus type 5 (BoHV-5) vaccine.
    Campos FS; Dezen D; Antunes DA; Santos HF; Arantes TS; Cenci A; Gomes F; Lima FE; Brito WM; Filho HC; Batista HB; Spilki FR; Franco AC; Rijsewijk FA; Roehe PM
    Vet Microbiol; 2011 Feb; 148(1):18-26. PubMed ID: 20828945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the long-term effect of vaccination on transmission of infectious bovine rhinotracheitis virus in cattle herds hyperimmunized with glycoprotein E-deleted marker vaccine.
    Ampe B; Duchateau L; Speybroeck N; Berkvens D; Dupont A; Kerkhofs P; Thiry E; Dispas M
    Am J Vet Res; 2012 Nov; 73(11):1787-93. PubMed ID: 23106465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Different Infectious Bovine Rhinotracheitis Marker Vaccines in Calves.
    Petrini S; Martucciello A; Righi C; Cappelli G; Torresi C; Grassi C; Scoccia E; Costantino G; Casciari C; Sabato R; Giammarioli M; De Carlo E; Feliziani F
    Vaccines (Basel); 2022 Jul; 10(8):. PubMed ID: 36016092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A triple gene mutant of BoHV-1 administered intranasally is significantly more efficacious than a BoHV-1 glycoprotein E-deleted virus against a virulent BoHV-1 challenge.
    Chowdhury SI; Wei H; Weiss M; Pannhorst K; Paulsen DB
    Vaccine; 2014 Sep; 32(39):4909-15. PubMed ID: 25066735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction, characterization and immunogenicity of a glycoprotein E negative bovine herpesvirus-1.1 Egyptian strain "Abu-Hammad".
    El-Kholy AA; Rady DI; Abdou ER; Elseafy MM; Abdelrahman KA; Soliman H
    J Virol Methods; 2013 Dec; 194(1-2):74-81. PubMed ID: 23962750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of three commercial ELISA kits for detection of BOHV-1 gE specific antibodies in serum and milk samples and applicability of bulk milk for determination of herd status.
    Tignon M; De Baere M; Hanon JB; Goolaerts A; Houtain JY; Delooz L; Cay AB
    J Virol Methods; 2017 Jul; 245():66-72. PubMed ID: 28363451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of latency associated with glycoprotein E (gE) seroconversion after bovine herpesvirus 1 infection in calves with high levels of passive antibodies lacking gE antibodies.
    Schynts F; Lemaire M; Ros C; Belak S; Thiry E
    Vet Microbiol; 2001 Sep; 82(3):211-22. PubMed ID: 11470543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of BoHV-1 gG-/tk-/gE- Mutant in Differential Protein Expression, Virulence, and Immunity.
    Marawan MA; Deng M; Wang C; Chen Y; Hu C; Chen J; Chen X; Chen H; Guo A
    Vet Sci; 2021 Oct; 8(11):. PubMed ID: 34822626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of an Immunization Protocol Using Bovine Alphaherpesvirus 1 gE-Deleted Marker Vaccines against Bubaline Alphaherpesvirus 1 in Water Buffaloes.
    Martucciello A; Balestrieri A; Righi C; Cappelli G; Scoccia E; Grassi C; Brandi S; Rossi E; Galiero G; Gioia D; Fusco G; Feliziani F; De Carlo E; Petrini S
    Vaccines (Basel); 2023 Apr; 11(5):. PubMed ID: 37242994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response to glycoprotein E after bovine herpesvirus type 1 infection in passively immunised, glycoprotein E-negative calves.
    Lemaire M; Schynts F; Meyer G; Thiry E
    Vet Rec; 1999 Feb; 144(7):172-6. PubMed ID: 10097325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of the immune response and virological protection of calves against bovine herpesvirus type 1 with an inactivated gE-deleted vaccine.
    Kerkhofs P; Renjifo X; Toussaint JF; Letellier C; Vanopdenbosch E; Wellemans G
    Vet Rec; 2003 May; 152(22):681-6. PubMed ID: 12803395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of live and inactivated infectious bovine rhinotracheitis vaccines.
    Frerichs GN; Woods SB; Lucas MH; Sands JJ
    Vet Rec; 1982 Aug; 111(6):116-22. PubMed ID: 6289508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hypervaccination with bovine herpesvirus type 1 gE-deleted marker vaccines on the serological response and virological status of calves challenged with wild-type virus.
    Toussaint JF; Rziha HJ; Bauer B; Letellier C; Kerkhofs P
    Vet Rec; 2004 Oct; 155(18):553-8. PubMed ID: 15559987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of BoAHV-1 Seronegative Latent Carrier by the Administration of Two Infectious Bovine Rhinotracheitis Live Marker Vaccines in Calves.
    Petrini S; Righi C; Costantino G; Scoccia E; Gobbi P; Pellegrini C; Pela M; Giammarioli M; Viola G; Sabato R; Tinelli E; Feliziani F
    Vaccines (Basel); 2024 Feb; 12(2):. PubMed ID: 38400144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of safety and efficacy of DNA vaccines against bovine herpesvirus-1 (BoHV-1) in calves.
    Petrini S; Ramadori G; Corradi A; Borghetti P; Lombardi G; Villa R; Bottarelli E; Guercio A; Amici A; Ferrari M
    Comp Immunol Microbiol Infect Dis; 2011 Jan; 34(1):3-10. PubMed ID: 19906427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.